Fortune Brands recently announced it will consolidate its U.S offices into one headquarters, taking over two of three office buildings previously owned by Horizon Therapeutics, then Amgen Inc., at ...

Khaite is in the midst of a retail expansion, with its first West Coast store opening at South Coast Plaza at the end of January, and a new lease signed for Los Angeles. Lauren Sanchez's Inaugural ...

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Eton Pharmaceuticals (ETON – Research Report), boosting the price ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company with a market capitalization of $1.6 billion focused on developing innovative therapies for challenging diseases, has been making ...

IBM, which already had at least 270,000 square feet at the 26-story Midtown South office building, signed a 15-year lease and ...

Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high ...

The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.

SAN DIEGO, CA - Dermata Therapeutics , Inc. (NASDAQ:DRMA) and Revance Therapeutics, Inc. (Nasdaq: NASDAQ:RVNC), two ...

NDAQ:HOTH) Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications ...

BTIG analyst Julian Harrison has maintained their bullish stance on SYRE stock, giving a Buy rating on January 14.Invest with Confidence: ...

Lil Gator Game dropped at the tail end of 2022 and has stood the test of time since as one of the coziest indie games ...

Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.